In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prof. Axel Ullrich: The New--Realistic--Biotech Era

Executive Summary

Perhaps Europe's leading academic entrepreneur, professor Axel Ullrich, PhD, joined Genentech in its infancy, then, returning to Germany as a director of the Max-Planck Institute, swam against a generally anti-commercial tide within the German academic community by founding Sugen and several German start-ups, most recently, U3 Pharma. He describes the aftermath of Germany's BioRegio program and a new dose of realism in European biotech.


Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts